Paradigm Biocapital Advisors LP Quant / Systematic

CIK: 0001855655 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $501,530 (100.0% shares, 0.0% debt)

Holdings (23)

LEGN LEGEND BIOTECH CORP 10.7%
Value ($000) $53,823 Shares 978,596 Est. Cost $43.19 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 9.2%
Value ($000) $46,186 Shares 1,445,566 Est. Cost $30.85 Unrealized
MIRATI THERAPEUTICS INC 8.8%
Value ($000) $44,304 Shares 659,968 Est. Cost $78.99 Unrealized
SIERRA ONCOLOGY INC 8.8%
Value ($000) $44,064 Shares 801,314 Est. Cost $26.80 Unrealized
INCY INCYTE CORP 8.4%
Value ($000) $42,243 Shares 556,043 Est. Cost $74.59 Unrealized +1.8%
ASND ASCENDIS PHARMA A/S 8.0%
Value ($000) $40,175 Shares 432,170 Est. Cost $119.79 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 7.7%
Value ($000) $38,425 Shares 163,066 Est. Cost $197.37 Unrealized +3.0%
ARGX ARGENX SE 6.7%
Value ($000) $33,651 Shares 88,816 Est. Cost $378.88 Unrealized
IMCR IMMUNOCORE HLDGS PLC 5.0%
Value ($000) $24,901 Shares 667,417 Est. Cost $32.64 Unrealized
ARVN ARVINAS INC 4.3%
Value ($000) $21,778 Shares 517,406 Est. Cost $74.11 Unrealized -32.3%
BCYC BICYCLE THERAPEUTICS PLC 3.5%
Value ($000) $17,594 Shares 1,048,516 Est. Cost $16.78 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 3.4%
Value ($000) $16,857 Shares 876,156 Est. Cost $17.65 Unrealized -5.6%
VRDN VIRIDIAN THERAPEUTICS INC 3.0%
Value ($000) $15,117 Shares 1,306,569 Est. Cost $18.45 Unrealized -27.1%
MERUS N V 2.0%
Value ($000) $10,239 Shares 452,244 Est. Cost $24.74 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 1.8%
Value ($000) $8,955 Shares 1,408,050 Est. Cost $6.75 Unrealized -16.0%
TGTX TG THERAPEUTICS INC 1.7%
Value ($000) $8,350 Shares 1,964,709 Est. Cost $6.24 Unrealized 0.0%
ALPINE IMMUNE SCIENCES INC 1.4%
Value ($000) $7,036 Shares 826,779 Est. Cost $8.70 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 1.4%
Value ($000) $7,006 Shares 148,216 Est. Cost $54.27 Unrealized 0.0%
VOR BIOPHARMA INC 1.3%
Value ($000) $6,482 Shares 1,304,300 Est. Cost $8.40 Unrealized
OYSTER PT PHARMA INC 1.2%
Value ($000) $5,773 Shares 1,333,330 Est. Cost $11.26 Unrealized
GRACELL BIOTECHNOLOGIES INC 0.9%
Value ($000) $4,309 Shares 783,445 Est. Cost $4.91 Unrealized
LQDA LIQUIDIA CORPORATION 0.7%
Value ($000) $3,710 Shares 850,961 Est. Cost $5.17 Unrealized 0.0%
CCCC C4 THERAPEUTICS INC 0.1%
Value ($000) $552 Shares 73,149 Est. Cost $32.19 Unrealized -72.7%